Xenon Issues Updates on Two of Its Investigational Drug Candidates
Skitterphoto / Pixabay

Xenon Issues Updates on Two of Its Investigational Drug Candidates

According to a story from globenewswire.com, the biopharmaceutical company Xenon Pharmaceuticals, Inc., recently announced the latest updates on the progress of two of its experimental products. The first is called…

Continue Reading Xenon Issues Updates on Two of Its Investigational Drug Candidates
This Research Partnership Will Investigate the Relationship Between Obesity and Pancreatic Cancer
Films42 / Pixabay

This Research Partnership Will Investigate the Relationship Between Obesity and Pancreatic Cancer

According to a story from prweb.com, researchers from the Johns Hopkins Kimmel Cancer Center and the Allegheny Health Network (AHC) Cancer Institute have entered a partnership that plans to investigate…

Continue Reading This Research Partnership Will Investigate the Relationship Between Obesity and Pancreatic Cancer
After The Death of a Loved One, This Couple is Determined to Find a Treatment for Fatal Familial Insomnia
AndCan / Pixabay

After The Death of a Loved One, This Couple is Determined to Find a Treatment for Fatal Familial Insomnia

According to a story from wired.com, everything changed for Sonia Vallabh and her husband Eric Minikel after Sonia's mother died from a mysterious illness. Sonia's mother Kamni was in her…

Continue Reading After The Death of a Loved One, This Couple is Determined to Find a Treatment for Fatal Familial Insomnia
Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit
source: pixabay.com

Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit

Notable Labs Notable Labs was created after founder, Matt De Silva, felt he was left in a helpless point, following a year of research on treatment options for his father's Glioblastoma…

Continue Reading Industry First: For-Profit Donates Rights of Potential New Pediatric Leukemia Drug to Non-Profit
Results of Levodopa Study Highlight Why Better Parkinson’s Disease Therapies are Needed
sabinevanerp / Pixabay

Results of Levodopa Study Highlight Why Better Parkinson’s Disease Therapies are Needed

According to a story from Parkinson's News Today, a recent study published in the New England Journal of Medicine highlights the key weakness of Levodopa, one of the most common treatments…

Continue Reading Results of Levodopa Study Highlight Why Better Parkinson’s Disease Therapies are Needed
Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial
qimono / Pixabay

Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial

According to a story from statnews.com, the biotechnology company Alexion Pharmaceuticals recently announced that its product Ultomiris, which was recently approved as a treatment for paroxysmal nocturnal hemoglobinuria, was also…

Continue Reading Recently Approved Drug Ultomiris Performs Well in Atypical Hemolytic Uremic Syndrome Trial

Phase 2 Trial Results for Epidermolysis Bullosa Coming Second Quarter of 2019

Epidermolysis Bullosa Epidermolysis Bullosa (EB) refers to a group of rare conditions which are characterized by fragile skin. Basically, the disease is caused by separation between the layers of the skin.…

Continue Reading Phase 2 Trial Results for Epidermolysis Bullosa Coming Second Quarter of 2019
Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients
source: pixabay.com

Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients

The most common treatment for someone who is discovered to have early stage kidney cancer is surgery. The patient's tumors and a part of their kidneys are removed through a…

Continue Reading Computer Simulation Shows Surgery is Overprescribed for Kidney Cancer Patients